Literature DB >> 2598490

Induction of hair growth in alopecia totalis with diphencyprone sensitization.

B Monk.   

Abstract

The therapeutic use of the induction of an allergic contact sensitivity to diphencyprone in alopecia areata has been studied. Fourteen subjects had alopecia totalis and four had extensive and long-standing alopecia areata. Topical diphencyprone was capable of inducing an allergic contact sensitivity in 16 subjects (89%), and 13 of these agreed to proceed to repeated intermittent applications to the left side of the scalp, the right side acting as an untreated control; six subjects achieved cosmetically useful regrowth of normally pigmented terminal hair. No clinical features seemed to distinguish those who showed a favourable response from those who did not.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2598490     DOI: 10.1111/j.1365-2230.1989.tb00915.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

Review 1.  Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.

Authors:  Ralph M Trüeb; Maria Fernanda Reis Gavazzoni Dias
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Generalized molluscum contagiosum in an HIV patient treated with diphencyprone.

Authors:  Leena Chularojanamontri; Papapit Tuchinda; Kanokvalai Kulthanan; Woraphong Manuskiatti
Journal:  J Dermatol Case Rep       Date:  2010-12-31

Review 3.  Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update.

Authors:  Thipprapai Mahasaksiri; Chaninan Kositkuljorn; Tanaporn Anuntrangsee; Poonkiat Suchonwanit
Journal:  Drug Des Devel Ther       Date:  2021-03-23       Impact factor: 4.162

4.  Topical immunotherapy with diphenylcyclopropenone is effective and preferred in the treatment of periungual warts.

Authors:  Yunseok Choi; Do Hun Kim; Sang Yun Jin; Ai-Young Lee; Seung Ho Lee
Journal:  Ann Dermatol       Date:  2013-11-30       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.